ArticleCurrent microbiology2025
Analysis of Clinical Gram-Negative Carbapenem Resistant Acinetobacter baumannii and Klebsiella pneumoniae Isolates from Wounds of Patients at a Hospital Reveals Complex Resistome and the First Report of bla
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance poses a critical global threat, with carbapenem-resistant pathogens representing a significant challenge to healthcare systems. This study aimed to characterize carbapenem-resistant pathogens isolated from wound infections in patients from a major hospital in Trinidad using a combination of traditional microbiological and molecular techniques. A total of 25 Gram-negative bacterial isolates were analyzed phenotypically for antimicrobial resistance and genetically profiled for resistance mechanisms using polymerase chain reaction and whole genome sequencing. Analysis of the data revealed most of the isolates were Acinetobacter baumannii (A. baumannii) (56%; n = 14) and Klebsiella pneumoniae (K. pneumoniae) (28%; n = 7), but a small number of Enterobacter (12%; n = 3), and Pseudomonas (4%; n = 1) were also identified. While the isolates were determined to be carbapenem resistant, 32% (n = 8) also exhibited extended spectrum beta-lactamases characteristics. Key resistance determinants identified from whole genome sequencing included bla
Indexed as
Identifiers
41191144What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.